Since the introduction of the polymerase chain reaction (PCR), bodily fluids and excretions have become accessible to molecular genetic analysis. Detection of shedded tumor cells or identification of pathogens in excretions by PCR may be of great diagnostic value in the future. Recently, tumor cells harboring mutated K-rasgenes have been detected in stool samples of patients with colorectal or pancreatic cancer (3, 9) . Previous protocols for the isolation of DNA from stool are timeconsuming and laborious because of the requirement for several steps of phenol-chloroform extraction, an overnight digestion by proteinase K, filtration and further purification (3, 5, 9) . Efficient isolation of nucleic acids from agarose, blood or urine by binding to glass in the presence of chaotropic agents had been reported previously (2, 10) . Based on this principle, we developed a fast, less cumbersome and reliable method for the isolation of DNA from stool by direct binding to glass membranes in the presence of a solution of high molar guanidinium-isothiocyanate (GIT), obtaining DNA suitable for PCR in less than 30 min. In addition, this method was used successfully for the isolation of DNA from various bodily fluids.
The extraction method and PCR conditions are as follows:
Approximately 1 g of fresh or frozen (-80°C) stool sample was resuspended in 5 mL of 6 M ultrapure GIT dissolved in water (Life Technologies, Schwalbach, Germany) by vortex mixing vigorously. The inhomogeneous suspension was transferred by decanting to microcentrifuge tubes and then centrifuged for 5 min at 14000 rpm (Model 5415; Eppendorf, Berlin, Germany). Nonidet ® P-40 (NP40) was added to a final concentration of 1% and samples were incubated for 10 min at room temperature. At this stage, storage of samples at -20°C for at least one year had no effect on efficiency of amplification. After incubation, 500 µ L of suspension were applied to a glass membrane DNA isolation spin cartridge system (GLASS MAX ® ; Life Technologies) and centrifuged for 20 s at 14000 rpm at room temperature. The membrane was washed twice with 500 µ L of 4°C cold ethanol (70% in water). Afterwards the DNA was eluted with 100 µ L of 70°C hot water. For prevention of autocatalytic degradation of nucleic acids, longterm storage of DNA should be performed by the addition of Tris-HCl (pH 7.4) to a final concentration of 10 mM.
DNA from blood, pancreatic juice obtained during endoscopy, urine and sputum were isolated in a similar way without clarifying by centrifugation. Samples had been stored at -20°C and were thawed prior to preparation. Five microliters of blood, 50 µ L of pancreatic juice and 50 µ L of sputum, respectively, were used for preparation, NP40 was added to a final concentration of 1% and samples were supplemented with 6 M GIT to a final volume of 500 µ L. For reduction of viscosity 2-mercaptoethanol (Sigma Chemical, Deisenhofen, Germany) was added to sputum at a final concentration of 1% prior to incubation. For isolation of DNA from urine, 2 mL of fresh urine were centrifuged at 1 4 000 rpm for 5 min and the pellet was resuspended in 450 µ L GIT. A detailed summary of the 
of each of the following two primers: K ras -5 ′ (5 ′ -ACTGA -ATATAAACTT GTGGTAGT TGGACC-T-3 ′ ) and Kras -3 ′(5 ′ -TCAAAGA-ATGGTCCTGCACC-3 ′ ). Primer sequences and PCR conditions have been described previously (7) and were adopted with slight modifications. Hot start PCR was carried out on a thermal cycler (Biozym Minicycler ™; MJ Research, Oldendorf, Germany) with initial denaturation at 95°C for 5 min followed by 35 cycles of 95°C for 1 min, annealing at 55°C for 1 min and extension at 72°C for 2 min. The time periods for annealing and extension were relatively long due to application of a mismatched 5 ′ -primer (K-ras -5 ′ ) for subsequent analysis of mutations as described previously (7) . Terminal extension was performed at 72°C for 10 min. The PCR products (10 µ L) were analyzed by agarose gel electrophoresis (2.5%) and ethidium bromide staining.
PCR products of the expected size of 157 bp were detected in DNA from stool samples of 10 different individuals (Figure 1) . Sequencing of PCR products revealed that human K-ras had been amplified (data not shown), demonstrating that amplification of coextracted nucleic acids from other sources [e.g., of ingested food (1,6)] can be excluded. Weak signals were obtained reproducibly in three samples (Figure 1; lanes 4, 7 and 9 ) and may have been caused by either isolation of low amounts of DNA or inefficient amplification due to incomplete removal of inhibitors of PCR present in stool (4) . Strong amplification signals were obtained when well amplifiable genomic DNA isolated by standard protocols was added to the sample. This excluded incomplete removal of inhibitors as the cause for the weak amplification signals in these samples (data not shown). Low yields of DNA, therefore, are the most likely explanation for the weak amplification signals. The low yields may be either due to low amounts of cells present in these stool samples, decreased stability of cells and DNA, respectively, or due to binding of large amounts of nonspecific DNA to the glass membrane, causing competition for binding of specific DNA. Differences in the number of cells is an unlikely reason, as recovery of comparable amounts of cells from stool samples of various subjects at different points of time have been reported previously (1) . Decreased stability of cells may be a cause of weak amplification signals, as stool samples were kept (due to logistic reasons) for variable time periods, but not longer than 24 h at 4°C prior to long-term storage at -80°C. Immediate freezing of stool samples may improve results. For unknown reasons, nonspecific amplification occurred reproducibly in DNA from one stool sample (Figure 1 ; lane 9). In this case, strong K-ras -specific fragments were detectable by the application of nested PCR (data not shown).
Additionally, efficient amplification was obtained when our method was used for the extraction of DNA from blood, urine, pancreatic juice or sputum (Figure 2) , demonstrating that this protocol, without major modifications, is applicable for the isolation of DNA from different bodily fluids. Furthermore, in accordance with the results obtained from the isolation of DNA from stool, inhibitors of PCR known to be present at least in blood and urine (8) are efficiently removed by this extraction protocol.
To date, PCR products have been obtained successfully from stool samples from an additional 35 individuals. Amplification products were detectable without exception in 85 blood samples and 15 samples of pancreatic juice derived from different individuals, demonstrating the validity and reliability of the isolation protocol. Additionally, DNA suitable for amplification is obtained when urine and sputum samples are isolated by this protocol. Larger numbers of samples of urine and sputum need to be analyzed to confirm that the method presented here can be applied with comparable reliability as that observed for stool, blood and pancreatic juice.
In summary, by the method presented, DNA suitable for PCR can be isolated rapidly and efficiently from stool 
